Immediate Treatment for Acute Endophthalmitis
Immediate intravitreal injection of vancomycin and ceftazidime should be administered within 2 hours of presentation, as this timing is associated with the best visual outcomes. 1
Core Treatment Algorithm
Step 1: Immediate Intravitreal Antibiotics (Within 2 Hours)
- Vancomycin (for gram-positive coverage) + Ceftazidime (for gram-negative coverage)
- This combination provides 100% susceptibility coverage for bacterial organisms in most cases 2
- Speed is critical: treatment within 2 hours yields significantly better visual outcomes compared to delayed treatment 1
- Even patients with severe vision loss at presentation benefit most from expedited treatment 1
Step 2: Vitreous Tap for Culture
- Obtain vitreous sample before or during antibiotic injection
- Culture-positive endophthalmitis is associated with worse outcomes, making pathogen identification valuable 1
- High fungal culture rates (13.5%) highlight the need for cultures to guide potential antifungal therapy 2
Step 3: Decision on Immediate Vitrectomy
Consider immediate vitrectomy (within 24 hours) for:
- All cases if resources and expertise available, as recent evidence suggests improved outcomes regardless of presenting visual acuity 3, 4
- The Complete Early Vitrectomy for Endophthalmitis (CEVE) protocol demonstrates high effectiveness 4
The evidence landscape has evolved significantly:
- The classic EVS study (1995) suggested vitrectomy only for light perception vision, but surgical techniques have advanced considerably since then 5, 6
- Modern small-gauge (23G, 25G) vitrectomy shows mean visual acuity improvement from LogMAR 2.26 to 1.21 with immediate surgery 3
- However, delayed vitrectomy is associated with 5.7 times higher re-intervention rates compared to initial tap-and-inject 7
Clinical Nuances
Timing Considerations
The median time to intervention in contemporary practice is 3.5 hours 1, 7, but outcomes are significantly better when treatment occurs within 2 hours 1. This represents a critical window where photoreceptor damage may be prevented.
Presenting Visual Acuity as Prognostic Factor
Visual acuity at diagnosis remains the strongest predictor of final outcome 7. However, this should not delay treatment—patients with worse presenting vision benefit most from rapid intervention 1.
Pathogen Spectrum
- Exogenous endophthalmitis (most common after cataract surgery, intravitreal injections): Coagulase-negative Staphylococcus (37.5%), other gram-positive organisms 2
- Endogenous endophthalmitis: Consider Candida albicans (20.6%) and MRSA, requiring systemic workup 2, 8
Common Pitfalls to Avoid
- Delaying treatment for imaging or extensive workup: Every hour counts—initiate antibiotics first
- Waiting for culture results: Empiric broad-spectrum coverage should begin immediately
- Underestimating fungal causes: Maintain high suspicion, especially in endogenous cases or when bacterial cultures are negative
- Choosing delayed vitrectomy: If vitrectomy is planned, perform it within 24 hours to minimize re-intervention risk 7
Post-Injection Management
- Systemic antibiotics are generally not required for exogenous cases (based on EVS findings)
- For endogenous endophthalmitis, identify and treat the systemic source (e.g., prostatic abscess, urinary tract infection) 8
- Monitor closely for complications: retinal detachment (17.8%), secondary glaucoma (9.3%) 3
Adjunctive Considerations
- Intravitreal dexamethasone has not shown significant impact on visual outcomes 9
- Consider antifungal agents (intravitreal amphotericin B or voriconazole) if fungal etiology suspected 2
The paradigm has shifted toward more aggressive early intervention: while tap-and-inject remains the minimum standard, immediate complete vitrectomy appears increasingly favorable in modern practice, particularly when performed by experienced vitreoretinal surgeons using small-gauge techniques 3, 4.